Skip to main content
Fax No
+20882080774
MIS Email
hajjaj@aun.edu.eg
Email:
hajjajabduallah@yahoo.com
Mobile
01010211566
Office
0020882411521
Google Scholar

Ph. D. In Applied bioorganic Chemistry (Carbohydrates in drug design) , Faculty of applied Biological sciences Gifu University, Japan , 2009
M. Sc. In Pharmaceutical Sciences (Pharmaceutical Organic Chemistry) , Faculty of Pharmacy Assiut University , 2003
B. Sc. In Pharmaceutical Sciences, Faculty of Pharmacy Assiut University , 1997     

 

Professor Faculty of Pharmacy, Assiut University , 2022

Associate Professor Faculty of Pharmacy, ِِAssiut University , 2017

Lecturer Faculty of Pharmacy, ِِAssiut University , 2009

Assistant Lecturer Faculty of Pharmacy, Assiut University , 2003

Demonstrator Faculty of Pharmacy, Assiut University , 1998


Acting Head of Department Faculty of Pharmacy, Assiut University ,since 2020-09-16 To 2/7/2022

Tutoring Experience for postgraduate students 

I. In progress:

A. One of the supervision committees for the following doctor theses:

   Mrs. Maha Qaid Mohammed Qahtan                                                             

B. One of the supervision committees for the following master theses:

      Two students: Mr. Kirolos A. Wassef and Ms. Gehad Hamdy     

II. Approved:

11. Exploration of some new organic compounds structurally related to paracetamol, ketotifen     and other drugs as anticancer, anti-inflammatory and anti-COVID-19 Agents" Dr. Omaima F. Ibrahim, (Approved August 2025).  Doctor  

10. "Synthesis of 1,2,3-tri-substituted indole derivatives of potential anticancer activity" Ms Basma   Salah Ali, (Approved December 2024).  Master 

9. “exploring the structure-activity relationship of novel derivatives of nitazoxanide; a broad-spectrum antimicrobial drug” Mr. Mahmoud Saleh, (Approved November 2023).  Master

8. “Design, synthesis and biological evaluation of some new compounds containing the moiety of anti- tubercular drug 4-aminosalicylic acid” Mrs. Maha Qaid Mohammed Qahtan, (Approved October 2023). Master

7. “Design, synthesis, and biological evaluation of Lavendustin A derivatives as anti-cancer agents”, Ms. Shimaa Ahmed Othman, (Approved October 2023).  Master

6. “Design, synthesis and biological evaluation of some new heterocyclic derivatives of 4-aminosalicylic acid as dual antimycobacterial and antiinflammatory agents”, Mr. Ahmed Mahmoud Mosafa Hassan, (Approved August 2023).  Master

5. “Synthesis, characterization and biological activity of some new heterocycles related to thieno[2,3-b]pyridine derivatives”, Mrs Omaima Fawzi Ibrahim Mansour, (Approved January 2021).  Master

4. “Synthesis and characterization of some new pyridine derivatives bearing styryl group” Safiyyah Abdullah Haidar Alwaleedy, (Approved November 2020).  Master 

3. “Design and Synthesis of New Triazole–Chalcone Hybrids of Potential Biological Activity” by Mr.Andrew Nabil. (Approved August 2019).  Master

2. "Synthesis and biological screening of new hybrid molecules containing 1,3,4-thiadiazole and 1,3-thiazolidine-4-one bearing benzylidene and isatin moietiesby Mr. Yasser M. Omar (Approved January 2018).  Master

1. "Synthesis of some 5-aminosalicylic acid derivatives of anti-inflammatory and anticancer activitiesby Mr. Mohamed K. S. El-Nagar (Approved January 2018).  Master

 

MemberShip

1- Member of American Chemical Society August 2020 till present

2. Assiut University Staff members club, November 1998 to till present.

3. Egyptian Syndicate of Pharmacists, July 1997 till present.

4. Japanese society of carbohydrate research 2006 to 2009.